Possible symptoms include: Nausea that feels different from your usual semaglutide experience Persistent stomach discomfort that does not follow the typical pattern Diarrhea or vomiting beyond what you experienced when starting the medication Bloating or cramping at unusual times relative to your injection These symptoms overlap with normal semaglutide side effects, which makes them easy to dismiss
The first one is allergic responses to milk-based proteins
Medicare hasn't released an estimate of how many Americans might qualify for the anti-obesity drugs under the program
Weight loss is maintained only with continued lifestyle changes and often continued medication use
However, based on preclinical data and early human trial findings, glucagon receptor co-activation in the context of concurrent GLP-1R and GIPR agonism is hypothesised to: Increase energy expenditure, potentially by promoting thermogenesis Enhance hepatic fat oxidation, which may reduce liver fat content Contribute to appetite suppression through central nervous system pathways These GCGR-mediated mechanisms are largely derived from preclinical and indirect human data and require confirmation in larger trials
The survey of more than 5,000 adults also found that 15 percent have used one at some point